Literature DB >> 19057276

Pulmonary tumor embolism: a rare cause of acute right heart failure with elevated D-dimers.

Robert Kridel1, Samir Myit, Jean-Claude Pache, Jean-Michel Gaspoz.   

Abstract

We report the case of a 49-year-old woman with a prior history of breast cancer who presented with a subacute course of progressive dyspnoea, culminating in cardiovascular collapse from acute right heart failure. D-dimer serum level was elevated. While a computed tomography of the chest was negative for pulmonary embolism, the autopsy study revealed multiple carcinomatous emboli in distal pulmonary arteries, veins, and lymphatics. Pulmonary tumor embolism may be more frequent than previously thought, and could be mistaken for pulmonary thrombo-embolism.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19057276     DOI: 10.1097/JTO.0b013e31818e107c

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  4 in total

Review 1.  Pathophysiology, clinics and diagnostics of non-thrombotic pulmonary embolism.

Authors:  Martina Montagnana; Gianfranco Cervellin; Massimo Franchini; Giuseppe Lippi
Journal:  J Thromb Thrombolysis       Date:  2011-05       Impact factor: 2.300

2.  Echocardiographic Assessment of Patients with Pulmonary Tumor Thrombotic Microangiopathy First Diagnosed in the Emergency Department.

Authors:  Minjoo Kim; Hee Yoon; Min Yeong Kim; Ik Joon Jo; Soo Yeon Kang; Guntak Lee; Jong Eun Park; Taerim Kim; Se Uk Lee; Sung Yeon Hwang; Won Chul Cha; Tae Gun Shin
Journal:  Diagnostics (Basel)       Date:  2022-01-20

3.  Respiratory failure in a cancer patient: pulmonary thrombotic microangiopathy.

Authors:  Robert M Venn; Emma Parkes; Anurag Joshi; Edward Jd Caple; Helen E Davies
Journal:  Clin Med (Lond)       Date:  2020-07       Impact factor: 2.659

4.  Pulmonary tumor embolism: A retrospective study over a 30-year period.

Authors:  Xin He; Douglas C Anthony; Zulmira Catoni; Weibiao Cao
Journal:  PLoS One       Date:  2021-08-11       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.